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depression. Normalization of unbalanced
serotonergic activity between the median
and dorsal raphe´ nuclei likely underlies
this beneficial effect.
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Despite the well-established role of serotonin
signaling in mood regulation, causal relationships
between serotonergic neuronal activity and behavior
remain poorly understood. Using a pharmacogenetic
approach, we find that selectively increasing seroto-
nergic neuronal activity in wild-type mice is anxio-
genic and reduces floating in the forced-swim test,
whereas inhibition has no effect on the same mea-
sures. In a developmental mouse model of altered
emotional behavior, increased anxiety and depres-
sion-like behaviors correlate with reduced dorsal
raphe´ and increased median raphe´ serotonergic ac-
tivity. These mice display blunted responses to sero-
tonergic stimulation and behavioral rescues through
serotonergic inhibition. Furthermore, we identify
opposing consequences of dorsal versus median
raphe´ serotonergic neuron inhibition on floating
behavior, together suggesting that median raphe´ hy-
peractivity increases anxiety, whereas a low dorsal/
median raphe´ serotonergic activity ratio increases
depression-like behavior. Thus, we find a critical
role of serotonergic neuronal activity in emotional
regulation and uncover opposing roles of median
and dorsal raphe´ function.INTRODUCTION
The involvement of serotonin (5-HT) in regulating emotional
behavior is firmly established (Nutt, 2002; Suri et al., 2015).
In fact, molecules that boost 5-HT signaling constitute the
most frequently prescribed psycho-active drugs on the mar-
kets today, with a primary indication for the treatment of
depression and anxiety disorders (Blier et al., 1990; Nutt,
2005). These drugs mainly increase 5-HT signaling by blocking
peri-synaptic 5-HT reuptake or cytosolic 5-HT degradation,Cell Reand proxies of decreased 5-HT signaling in patients further
support the 5-HT deficiency theory of depression (Jacobsen
et al., 2012). However, insight into the direct role of 5-HTergic
neuronal activity on behavior remains scarce and conflicting.
For example, several animal models of anxiety and depres-
sion-like behavior display reduced firing of 5-HTergic neurons,
implying a causal relationship (Bambico et al., 2009; Lira et al.,
2003), yet genetic blockade of 5-HTergic vesicular neurotrans-
mission reduces anxiety (Kim et al., 2009; Narboux-Ne^me
et al., 2011).
5-HTergic projections in the CNS arise from the brainstem
raphe´ nuclei. The dorsal raphe´ nuclei (DR) and the median raphe´
nuclei (MR) harbor the vast majority of 5-HTergic neurons that
innervate the forebrain and, as such, are considered most rele-
vant in modulating emotional behavior (Jacobs and Azmitia,
1992; Muzerelle et al., 2014). Despite this seemingly simple
anatomical setup, DR and MR 5-HTergic neurons have different
rhombomeric origins, functional specifications, and overlapping
regions of axonal projection (Bang et al., 2012; Brust et al., 2014;
Jensen et al., 2008; Muzerelle et al., 2014). Optogenetic stimula-
tion of MR neurons produces rapid activation of hippocampal in-
terneurons (Varga et al., 2009) and reduces the time spent in
open arms of the elevated plus maze (EPM) (Ohmura et al.,
2014). Optogenetic stimulation of medial prefrontal cortex
(mPFC) axons in the DR increases swimming behavior in the
forced-swim test (FST) (Warden et al., 2012), and direct optoge-
netic stimulation of 5-HTergic DR neurons biases reward-asso-
ciated behaviors (Liu et al., 2014). These studies establish a
causal relationship between raphe´ activity and behavior, but
the frequent lack of serotonergic specificity, the super-acute
and hyper-synchronous character of optogenetic stimulation
protocols, and the local activation of anatomically defined path-
ways provide an incomplete and biased picture of causal rela-
tionships between 5-HTergic neuronal activity and behavior.
To advance insight, we studied the consequences of bidirec-
tional pharmacogenetic manipulations of 5-HTergic neurons in
naive mice as well as in a developmental mouse model of
increased anxiety and depression-like behavior; i.e., mice
administered fluoxetine from post-natal day (P)2 to P11 (PNFLX)
(Ansorge et al., 2004; Rebello et al., 2014).ports 13, 1965–1976, December 1, 2015 ª2015 The Authors 1965
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Figure 1. Pharmacogenetic Modulation of 5-HTergic Neuronal Activity
(A) Time course of in vivo firing rates of putative DR 5-HTergic neurons for 30 min after CNO injection shows increased firing rates upon CNO injection in hM3Dq+
mice when compared to controls. Baseline is calculated using the last 3 min before CNO injection. n = 3–5 per genotype.
(B) Spike trace for a putative 5-HT neuron recorded in the DR of hM3Dq+ mice before (solid line) and 15 min after (dashed line) CNO injection.
(C) Firing rates of 5-HTergic neurons pooled by time before (15 to 0 min) and after (0 to 15 min and 15 to 30 min) CNO injection demonstrate an increase in
putative 5-HTergic neuronal firing rates in hM3Dq+ mice. n = 7 per genotype.
(D) Time course of changes in extracellular 5-HT levels in the mPFC of hM3Dq+ and respective control mice shows an hM3Dq+-dependent increase after CNO
injection. n = 2–4 per genotype.
(legend continued on next page)
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RESULTS
Bidirectional Manipulation of Serotonergic Neuronal
Activity via Conditional Expression of DREADDs in Mice
We first analyzed the consequence of manipulating 5-HT neu-
rons in vivo using two conditional DREADD mouse lines,
RC::PDq and RC::PDi. Both lines express the respective
DREADD (hM3Dq coupling to Gq and hM4Di coupling to Gi/o)
Cre dependently under control of the Chicken b-actin promoter
targeted to the (Gt)ROSA26Sor locus, and the RC::PDi line was
previously described (Brust et al., 2014; Ray et al., 2011) (Fig-
ure S1). DREADD expression was directed to 5-HTergic neurons
using the Pet1-cre line (Scott et al., 2005), and immunostaining
against 5-HT and hemagglutinin (HA) (with which both DREADDs
are tagged) confirmed the specificity of DREADD expression in
5-HTergic neurons (Figures S2A–S2F). Both DREADDs are spe-
cifically and selectively activated by clozapine-N-oxide (CNO)
(Armbruster et al., 2007). Hence, we next assessed the
hM3Dq- and hM4Di-dependent impact of CNO on 5-HTergic
neuronal activity by combining extracellular single-unit record-
ings in the DR with micro-dialysis in the mPFC in anesthetized
mice. Putative 5-HT neurons were identified based on a tri-
phasic shape and long duration of spikes (Figures 1B and 1H).
In DR neurons of RC::PDq;Pet1-cre mice, we observed a
progressive increase in putative 5-HT neuron activity through
longitudinal assessment during the first 30 min post-CNO
injection (Figure 1A); Genotype 3 Time interaction (GXTime),
F(31, 124) = 4.314, p < 0.0001; effect for genotype (G effect),
F(1, 124) = 27.934, p = 0.0061. Cross-sectional data analysis
also revealed increased putative 5-HT neuron activity at 15 min
and 30 min post-injection (t15 and t30, respectively) when
compared to genetic controls lacking the Pet1-cre transgene
(Figure 1C); GXTime, F(2, 20) = 12.036, p = 0.0004; or pre-injec-
tion activity (Fisher’s protected least significant difference
[PLSD] for hM3Dq+, p = 0.0149 for t15 and p = 0.0054 for t30).
Microdialysis in the mPFC revealed increased extracellular
5-HT levels in RC::PDq;Pet1-cre animals as compared to con-
trols after CNO injection; GXTime, F(4, 16) = 3.528, p = 0.0302;
G effect, F(1, 16) = 36.463, p = 0.0038 (Figure 1D). Next, we
analyzed immediate early gene induction and found increased
Fos+ 5-HT neurons after CNO treatment of RC::PDq;Pet1-cre
mice, as compared to their controls, in both the MR and DR
(Figures 1E and 1F and S2G–S2I); G effect, F(1, 26) = 24.265,
p < 0.0001, indicating increased 5-HTergic neuronal activity.
We did not find such an increase in non-5-HTergic neurons,
F(1, 9) = 0.486, p = 0.5033. In RC::PDi;Pet1-cre animals, we
observed a decrease in putative 5-HT neuron activity through(E and F) Fos and 5-HT double immunostaining on raphe´ sections reveals increa
controls in the DR and MR. n = 6–9 per genotype and region. Scale bar in (E), 10
(G) Time course of in vivo firing rates of putative 5-HTergic neurons for 30min after
when compared to controls. Baseline is calculated using the last 3 min before C
(H) Spike trace for a putative 5-HT neuron recorded in the DR of hM4Di+ mice be
(I) Firing rates of 5-HTergic neurons pooled by time before (15 to 0min) and after
5-HTergic neuronal firing rates in hM4Di+ mice. n = 5–7 per genotype.
(J) Time course of changes in extracellular 5-HT levels in the mPFC of hM4Di+ a
(K and L) Fos and 5-HT double immunostaining on raphe´ sections reveals decre
controls in the DR and MR. n = 6–9 per genotype and region.
Data are presented as mean ± SEM. #p < 0.1; *p < 0.05; **p < 0.01; ***p < 0.001
Cell Relongitudinal assessment during the first 30 min post-CNO injec-
tion (Figure 1G); GXTime, F(31, 124) = 1.195, p = 0.2446; G effect,
F(1, 124) = 7.976, p = 0.0476; and in a cross-sectional assess-
ment at t15 and t30 when compared to genetic controls lacking
the Pet1-cre transgene (Figure 1I); GXTime, F(2, 20) = 4.094,
p = 0.0323; or pre-injection activity (Fisher’s PLSD, p = 0.0390
for t15 and p = 0.1058 for t30; of note, we did not detect a corre-
lation between spike width and change in firing rate after CNO;
Figure S3). Throughmicro-dialysis, we could not detect an effect
of CNO/hM4Di on extracellular 5-HT levels (Figure 1J), possibly
due to mechanisms regulating local 5-HT homeostasis. How-
ever, immediate early gene analysis again confirmed reduced
activation of 5-HT+ neurons in RC::PDi;Pet1-cre mice, when
compared to their controls, in both the MR and DR (Figures 1K
and 1L and S2G–S2I); G effect, F(1, 22) = 21.24, p = 0.0252.
We did not find such a decrease in non-5-HTergic neurons,
F(1, 9) = 0.407, p = 0.5394. Together, these data demonstrate
efficient bidirectional manipulation of 5-HTergic neuronal
activity.Increased 5-HTergic Neuronal Activity Increases Levels
of Anxiety-Related Behaviors and Swimming Behavior,
whereas Decreased 5-HTergic Neuronal Activity Does
Not Impact Emotional Behavior
Next, we evaluated the effect of CNO administration to
RC::PDq;Pet1-cre and RC::PDi;Pet1-cre mice on anxiety and
depression-like behavior, controlling for treatment (vehicle
[Veh] versus CNO, 1 mg/kg, intraperitoneally; i.p.) and geno-
type (littermate controls). For RC::PDq mice, we detected a Ge-
notype 3 Treatment (GXTx) interaction on distance traveled in
the open field (OF), F(1, 34) = 5.709, p = 0.0226 (Figure 2A);
and in the EPM, F(1, 33) = 6.756, p = 0.0139 (Figure 2D); this sug-
gests a global decrease in exploration of a novel environment.
Likewise, we also observed GXTx interactions for measures
that are sensitive to anxiolytic treatment: time spent rearing in
the OF, time spent in the open arm of the EPM, and time
spent in the distal part of the open arm in the EPM: OF
rearing, F(1, 34) = 9.856, p = 0.0035; EPM open arm time,
F(1, 33) = 7.42, p = 0.0102; EPM distal open arm time,
F(1, 33) = 5.988, p = 0.0199 (Figures 2B, 2E, and 2F). The
number of center entries in the OF did not reach significance,
F(1, 34) = 2.803, p = 0.1033; but it displayed a similar pattern (Fig-
ure 2C). Post hoc analysis revealed that RC::PDq;Pet1-cre
animals displayed an anxiogenic-like response to CNO/Gq-
mediated manipulation of neuron activity (Figures 2B, 2E, and
2F). In contrast, activity in the home-cage was not affected bysed Fos+ staining in 5-HT+ neurons in hM3Dq+ mice when compared to their
0 mm.
CNO injection shows decreased firing rates uponCNO injection in hM4Di+mice
NO injection. n = 3–4 per genotype.
fore (solid line) and 15 min after (dashed line) CNO injection.
(0 to 15min and 15 to 30min) CNO injection demonstrate a decrease in putative
nd respective control mice. n = 2–5 per genotype.
ased Fos+ staining in 5-HT+ neurons of hM4Di+ mice when compared to their
.
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Figure 2. Behavioral Consequences of Increasing 5-HTergic Neuronal Activity
(A–C) hM3Dq+mice exposed to CNOdisplay decreased distance traveled (A), rearing events (B), and number of entries to the center (C) in theOFwhen compared
with hM3Dq controls exposed to CNO or hM3Dq+ mice exposed to Veh. n = 6–12 per genotype and treatment.
(D–F) hM3Dq+mice exposed to CNOdisplay decreased distance traveled (D), time spent in the open arm (E), and time spent in the distal part of the open arm (F) in
the EPM when compared with hM3Dq controls exposed to CNO or hM3Dq+ mice exposed to Veh. n = 6–12 per genotype and treatment.
(G and H) Time spent floating during 6min of the FST after Veh (G) and CNO (H) injections shows a reduction in floating specific to hM3Dq+mice exposed to CNO.
n = 15–25 per genotype and treatment.
(I) During the last 3 min of the FST, hM3Dq+ mice float less when exposed to CNO. n = 15–25 per genotype and treatment.
Data are presented as mean ± SEM. *p < 0.05; **p < 0.01; ***p < 0.001.genotype or treatment (Figure S4), supporting the interpretation
of an anxiogenic effect of increased neuronal 5-HTergic activity.
Next, we assessed escape behavior in the Porsolt FST,
which serves as a proxy for behavioral despair and is sensitive
to antidepressant treatment (Castagne´ et al., 2011; Porsolt
et al., 1977). Because this test can be repeated (Mezadri
et al., 2011), we used a crossover design for treatment,
allowing for within-animal repeated-measures analysis. In
RC::PDq;Pet1-cre mice, we confirmed the absence of G effect
upon Veh exposure, F(1, 190) = 1.446, p = 0.2366 (Figure 2G);
and we found an effect of treatment, F(1, 190) = 7.420,
p = 0.0097 (Figure 2H). For minutes 4–6, we detected a GXTx
interaction, F(1, 38) = 9.492, p = 0.0038, where the mutant an-
imals spent less time floating after exposure to CNO when
compared to Veh, while control animals were unaffected by
the treatment (Figure 2I).
On the other hand, acute inhibition of 5-HTergic activity using
RC::PDi;Pet1-cre mice did not alter exploration in the OF (Fig-
ure 3A; GXTx: F(1, 24) = 0.022, p = 0.8846) or EPM (Figure 3D;
GXTx: F(1, 26) = 0.873, p = 0.3586), nor did it affect OF rearing1968 Cell Reports 13, 1965–1976, December 1, 2015 ª2015 The Autactivity (Figure 3B; F(1, 24) = 0.457, p = 0.5055), entries into the
center of the OF (Figure 3C; F(1, 24) = 0.138, p = 0.714), or
entries into the open arm of the EPM (Figures 3E and 3F;
F(1, 26) = 1.155, p = 0.2924). Finally, no effect of CNO was
observed in RC::PDi;Pet1-cre mice for time floating in the
FST (GXTx: F(1, 145) = 0.087, p = 0.9942) (Figures 3G–3I).
Altered Behavioral Response to Pharmacogenetic
Modulation of 5-HTergic Neuronal Activity in
PNFLX Mice
PNFLX animals (P2–P11) display a behavioral phenotype,
which closely phenocopies that of 5-HT transporter null
mutants (Slc6a4/), including increased anxiety and depres-
sive-like behaviors as well as altered social, sexual, and sleep
behaviors (Ansorge et al., 2004; Rebello et al., 2014; Silva
et al., 2010). As such, studying PNFLX mice provides insight
into the developmental origins of affective dysfunction. Here,
we investigated the behavioral consequences of altering
5-HTergic neuronal activity in PNFLX mice to gage global func-
tional 5-HTergic status and to test the hypothesis that alteredhors
AD E
I
B C
G H
F
To
ta
lD
is
ta
nc
e
(c
m
)
R
ea
rin
g 
Ev
en
ts
Ti
m
e 
O
pe
n 
Ar
m
 (s
ec
)
To
ta
lD
is
ta
nc
e
(c
m
)
0
20
40
60
80
100
120
140
160
180
0
400
800
1200
1600
2000
0
10
20
30
40
50
60
70
80
90
0
20
40
60
80
100
120
140
R
C
::P
D
i;P
et
1-
cr
e
 (i
nh
ib
iti
ng
) EPM EPM
FST
OF OF OF
0
5
10
15
20
25
C
en
te
r E
nt
rie
s
hM3Di+hM3Di
control
hM3Di+hM3Di
control
hM4Di
control
hM4Di+ hM4Di
control
hM4Di+
CNOCNO VehVeh
hM4Di
control
hM4Di+
hM4Di
control
hM4Di+hM4Di
control
hM4Di+
CNOCNO VehVeh
hM4Di
control
hM4Di+
CNOCNO VehVeh
Veh CNO
CNOCNO VehVeh
0
10
20
30
40
50
60
0
10
20
30
40
50
60
hM4Di+
hM4Di control
hM4Di+
hM4Di control
1 2 3 4 5 6
(min)
1 2 3 4 5 6
(min)
Ti
m
e 
flo
at
in
g 
(s
ec
)
Ti
m
e 
flo
at
in
g 
(s
ec
)
FST
Veh
FST
CNO
0
5
10
15
20
25
30
35
40
Ti
m
e 
D
is
ta
l O
pe
n 
Ar
m
 (s
ec
) EPM
CNOCNO VehVeh
0
1000
2000
3000
4000
5000
6000
7000
CNOCNO VehVeh
Fl
oa
tin
g 
D
ur
at
io
n 
la
st
 3
m
in
 (s
ec
)
Figure 3. Behavioral Consequences of Decreasing 5-HTergic Neuronal Activity
(A–C) hM4Di+ mice exposed to CNO display no phenotype in distance traveled (A), rearing events (B), and number of entries to the center (C) in the OF. n = 6–11
per genotype and treatment.
(D–F) Similarly, in the EPM, no difference could be detected for CNO-exposed hM4Di+ mice in the distance traveled (D), time spent in the open arm (E), and time
spent in the distal part of the open arm (F). n = 6–11 per genotype and treatment.
(G and H) Time spent floating during 6 min of the FST after Veh (G) and CNO (H) injections shows no difference between genotypes. n = 13–18 per genotype and
treatment.
(I) Time spent floating during the last 3 min of the test also shows no difference between hM4Di+ mice and controls upon Veh or CNO exposure. n = 13–18 per
genotype and treatment.
Data are presented as mean ± SEM.5-HTergic activity contributes to the behavioral phenotype
(Veerakumar et al., 2014).
Mice were injected from P2–P11 with fluoxetine (10 mg/kg/
day; PNFLX) or saline (PNSAL) (Figure 4A; Figure 5A). Because
we did not detect an effect of CNO in naiveRC::PDq andRC::PDi
control mice (Figures 2 and 3), all PNFLX and PNSAL animals
were injected with CNO 30 min before the onset of tests. In
RC::PDq;Pet1-cre mice, we found a Genotype 3 Post-natal
Treatment (PNT) interaction (GXPNT) in OF parameters,
demonstrating a differential response of CNO exposure in
RC::PDq;Pet1-cre mice as a function of PNT: OF distance,
F(1, 70) = 4.547, p = 0.0365; OF rearing, F(1, 70) = 6.024,
p = 0.0166; OF center entries, F(1, 70) = 5.890, p = 0.0178. For
the EPM and the novelty suppressed feeding test (NSF), we
detected G effects in distance, F(1, 50) = 16.987, p = 0.0001;
time in the open arm, F(1, 50) = 5.065, p = 0.0288; and latency
to feed, F(1, 58) = 12.62, p = 0.0008. Post hoc analysis showed
that PNFLX control animals explore less in the OF and EPM
than PNSAL controls (Figures 4B and 4E). PNFLX animals also
enter less frequently into the center of the OF, spend less timeCell Rein the open arm of the EPM, and take a longer time to eat in a
new environment (NSF) without any difference in their weight
loss (Figures 4D and 4F–4H). Next, we confirmed that PNSAL
RC::PDq;Pet1-cre mice display the same behavioral CNO
response profile as identified for naive RC::PDq;Pet1-cre mice
(Figures 1 and 4). By contrast, PNFLX RC::PDq;Pet1-cre mice
only displayed a significantly decreased distance traveled in
the OF and increased latency to bite the food pellet in the NSF
(Figures 4B and 4G). These data reveal a blunted behavioral
response to 5-HT neuronal activation in PNFLX animals when
compared to the effect of CNO in naive and PNSAL mice. In
the FST, we confirmed an absence of G effect upon Veh treat-
ment (Figure 4I)—repeated ANOVA, F(1, 150) = 1.728, p =
0.1986—while we observed a G effect and a PNT effect upon
CNO exposure: for G effect, F(1, 110) = 15.188, p = 0.0008; for
PNT, F(1, 110) = 6.788, p = 0.0162 (Figure 4J). Finally, for floating
behavior during min 4–6, we observed a PNT3 Treatment inter-
action, F(1, 53) = 4.989, p = 0.0297; and a GXTx interaction,
F(1, 53) = 4.143, p = 0.0468. Post hoc analyses revealed
decreased floating in PNSAL RC::PDq;Pet1-cre mice exposedports 13, 1965–1976, December 1, 2015 ª2015 The Authors 1969
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Figure 4. Behavioral Consequences of Increasing 5-HTergic Neuronal Activity in PNFLX Mice
(A) Schematic of experimental groups: hM3Dq+ mice (orange bars) and hM3Dq controls (gray bars) were injected with saline (PNSAL, plain bars) or FLX (PNFLX,
dashed bars) from P2 to P11 and were submitted to behavioral tests upon CNO injections starting after P90.
(B–D) In the OF, PNSAL hM3Dq+ mice display decreased distance traveled (B), rearing events (C), and number of entries to the center (D) when compared to
hM3Dq controls, while this response is blunted in PNFLX hM3Dq+ mice as compared with PNFLX hM3Dq controls. n = 7–11 per genotype and PNT.
(E and F) In the EPM, PNSAL hM3Dq+ mice display decreased distance traveled (E) and open arm time (F). n = 11–16 per genotype and PNT.
(G and H) Latency to bite the pellet in the NSF test is significantly increased in both PNSAL and PNFLX hM3Dq+ mice as compared with their controls (H). No
change in the percent weight loss was observed between PNSAL or PNFLX hM3Dq+ mice and their respective controls (H). n = 13–15 per genotype and PNT.
(I and J) In the FST, PNSAL and PNFLX hM3Dq+ mice spent less time floating during 6 min of the test upon CNO (J) but not Veh (I) injections when compared to
their respective hM3Dq controls. n = 13–16 per genotype and PNT.
(K) During the last 3 min of the FST, PNSAL hM3Dq+ mice float less after CNO exposure when compared to Veh treatment. n = 13–16 per genotype and PNT.
Data are presented as mean ± SEM. #p < 0.1; *p < 0.05; **p < 0.01; ***p < 0.001.to CNO when compared to Veh exposure or controls but not in
PNFLX RC::PDq;Pet1-cre mice, again supporting a blunted
response in PNFLX animals (Figure 4J). In summary, our exper-
iments demonstrate anxiogenic and antidepressant-like effects
of increasing 5-HTergic neuronal activity, with PNFLX animals
displaying a blunted response.
These data support a general model in which early-life in-
crease in 5-HT signaling impacts the maturation of the 5-HT sys-
tem to leave the adult brain with altered global 5-HT function. The
anxiogenic effect of stimulating 5-HTergic neuronal activity,
furthermore, is suggestive of a hyperfunction in the 5-HT system
of PNFLX animals. Hence, we next assessed the consequences
of transiently decreasing 5-HTergic neuronal activity in PNFLX
animals and PNSAL controls. We detected a GXPNT and a G ef-
fect for the latency to feed in the NSF—for GXPNT, F(1, 44) =
4.592, p = 0.0377; for G effect, F(1, 44) = 13.481, p = 0.0006 (Fig-
ure 5G)—and a G effect for EPM open-arm time, F(1, 40) = 7.193,
p = 0.0106 (Figure 5F). We also detected a PNT effect for dis-
tance traveled in the OF, F(1, 41) = 4.111, p = 0.0491; and the
time to feed in the NSF, F(1, 44) = 4.53, p = 0.0292. In post hoc1970 Cell Reports 13, 1965–1976, December 1, 2015 ª2015 The Autanalyses, no differences were detected between PNSAL and
PNFLX RC::PDi;Pet1-cre mice and their respective controls in
distance traveled in the OF or the EPM, or in the number of rear-
ing events (Figures 5B, 5C, and 5E). However, PNFLX RC::PDi;
Pet1-cre mice displayed an increased number of entries into
the center of the OF (Figure 5D), increased time spent in the
open arm of the EPM (Figure 5F), and decreased time to bite
the pellet in the NSF, as compared to PNFLX control animals
(Figure 5G). Even though we detected a G effect on the control
measure weight loss in the NSF, F(1, 44) = 4.612, p = 0.0373 (Fig-
ure 5H), this effect is unlikely to account for the interaction effect
on latency to bite.
In summary, CNO binding to hM4Di in 5-HTergic neurons
does not impact anxiety-related behaviors in naive or PNSAL
mice, whereas it reduces respective measures of the OF,
EPM, and NSF in PNFLX mice. Moreover, upon CNO injections,
PNFLX RC::PDi;Pet1-cre mice exhibit anxiety levels very similar
to those of PNSAL controls, suggesting a rescue of their anxi-
ety phenotype upon decreasing 5-HTergic neuronal activity.
Behavioral sensitivity of PNFLX mice to reducing 5-HTergichors
##
#
*
**
*
*
*
*
*
***
*
PN
FL
X
PN
SA
L
PN
FL
X
R
C
::P
D
i;P
et
1-
cr
e 
 (i
nh
ib
iti
ng
)
OF OF
C
OF
D
PNFLX, hM3Di+
PNFLX, hM3Di control
PNSAL, hM3Di+
PNSAL, hM3Di control
Veh CNO
FST
I
FST
J
FST
K
CNO
%
 W
ei
gh
t L
os
s
To
ta
lD
is
ta
nc
e
(c
m
)
To
ta
lD
is
ta
nc
e
(c
m
)
La
te
nc
y 
to
 B
ite
 (s
ec
)
Ti
m
e 
O
pe
n 
Ar
m
 (s
ec
)
0
20
40
60
80
100
120
140
0
20
40
60
80
100
120
140
160
0
20
40
60
80
100
120
140
0
200
400
600
800
1000
1200
1400
1600
1800
R
ea
rin
g 
Ev
en
ts
C
en
te
r E
nt
rie
s
0
2
4
6
8
10
12
14
16
0
10
20
30
40
50
60
1 2 3 4 5 6
0
10
20
30
40
50
60
0
2
4
6
8
10
12
14
0
500
1000
1500
2000
2500
3000
Ti
m
e 
flo
at
in
g 
(s
ec
)
BA
EPMEPM NSF
G
NSF
HFE
CNO
P90+ P2-11
PNSAL
PNFLX
PNSAL
PNFLX
hM
4D
i
co
nt
ro
l
hM
4D
i+
hM4Di
control
hM4Di+
PNFLXPNSAL PNFLXPNSAL
hM4Di
control
hM4Di+
PNFLXPNSAL PNFLXPNSAL
hM4Di
control
hM4Di+
PNFLXPNSAL PNFLXPNSAL
hM4Di
control
hM4Di+
PNFLXPNSAL PNFLXPNSAL
hM4Di
control
hM4Di+
PNFLXPNSAL PNFLXPNSAL
hM4Di
control
hM4Di+
PNFLXPNSAL PNFLXPNSAL
hM4Di
control
hM4Di+
PNFLX
PNSAL PNFLXPNSAL
hM3Di
control
hM3Di+P
N
SA
L
PN
FL
X
PN
SA
L
PN
FL
X
(min)
Fl
oa
tin
g 
D
ur
at
io
n 
la
st
 3
m
in
 (s
ec
)
PN
SA
L
PNFLX, hM4Di+
PNFLX, hM4Di control
PNSAL, hM4Di+
PNSAL, hM4Di control
Veh60
0
10
20
30
40
50
1 2 3 4 5 6
Ti
m
e 
flo
at
in
g 
(s
ec
)
(min)
Figure 5. Behavioral Consequences of Decreasing 5-HTergic Neuronal Activity in PNFLX Mice
(A) Schematic of experimental groups: hM4Di+ mice (blue bars) and hM4Di controls (gray bars) were injected with saline (PNSAL, plain bars) or FLX (PNFLX,
dashed bars) from P2 to P11 and were submitted to behavioral tests upon CNO injections starting after P90.
(B–D) In the OF, PNSAL and PNFLX hM4Di+ mice have similar distance traveled (B) and rearing events (C) when compared to their respective hM4Di controls, but
PNFLX hM4Di+ mice display an increased number of entries to the center (D) when compared to PNFLX hM4Di controls. n = 10–13 per genotype and PNT.
(E and F) In the EPM, no significant difference between PNSAL and PNFLX hM4Di+ mice and their respective controls could be observed in the distance traveled
(E), but PNFLX hM4Di+ mice display increased time spent in the open arm when compared to PNFLX hM4Di controls (F). n = 11–16 per genotype and PNT.
(G and H) In the NSF, the latency to bite the pellet is significantly decreased in both PNSAL and PNFLX hM4Di+ mice as compared with their controls (H). An
increase in the percent weight loss was observed for hM4Di+ mice and as compared to hM4Di controls (H). n = 9–16 per genotype and PNT.
(I and J) In the FST, time spent floating during 6 min is significantly decreased upon CNO (J) but not Veh (I) injections only in PNFLX hM4Di+ mice as compared to
their hM4Di littermate controls. n = 9–14 per genotype and PNT.
(K) Time spent floating during the last 3 min of the test shows significant decrease in floating for both PNSAL and PNFLX hM4Di+ mice exposed to CNO when
compared to Veh injection. n = 13–16 per genotype and PNT.
Data are presented as mean ± SEM. #p < 0.1; *p < 0.05; **p < 0.01; ***p < 0.001.neuronal activity indicates that their baseline behavioral pheno-
type is, in part, determined by an altered balance in 5-HTergic
pathways regulating such behavior and that, by reducing over-
all 5-HTergic neuronal activity, normal balance is restored. In
the FST, for floating over time, we detected a PNT effect,
F(1, 190) = 6.360, p = 0.0160; and a trend for a G effect,
F(1, 190) = 3.79, p = 0.059, upon CNO exposure (Figures 5I
and 5J); and a GXTx interaction as well as a PNT effect for
floating during min 4–6: F(1, 38) = 5.810, p = 0.0209; and
F(1, 38) = 4.774, p = 0.0351, respectively (Figure 5K). Further-
more, post hoc analysis revealed decreased floating duration
upon CNO injections affecting both PNSAL and PNFLX
RC::PDi;Pet1-cre mice during min 4–6, and only PNFLX
RC::PDi;Pet1-cre mice for repeated assessment over min 1–6
(Figure 4J). These results are surprising in that they demon-
strate that reducing and activating 5-HTergic neuronal activity
can have similar effects on behavior. However, in the context
of an underlying model of unbalanced pathways, both reducingCell Reand increasing 5-HTergic neuronal activity can normalize bal-
ance, further supporting such a mechanism.
Altered Balance in DR versus MR Raphe´ Activity
Underlies PNFLX Induced Behavioral Phenotype
To further dissect how PNFLX animals respond to pharmaco-
genetic manipulation of 5-HT neurons, we performed co-label-
ing of 5-HT and Fos on raphe´ sections of PNFLX and PNSAL
RC::PDq;Pet1-cre and RC::PDiPet1-cre mice and their respec-
tive controls, sacrificed 2 hr after CNO injection (Figures 6A–
6C). We counted the number of Fos+ nuclei among 5-HT+
neurons in both DR (Figures 6A and 6C) and MR (Figure 6B),
as identified by their anatomic location. We found an overall
GXPNT interaction, F(2, 45) = 6.836, p = 0.0026. Notably,
PNSAL RC::PDq;Pet1-cre mice show a more-than-2-fold in-
crease in the percentage of Fos+/5-HT+ neurons (p < 0.001),
while PNFLX RC::PDq;Pet1-cre mice only show a 1.3-fold in-
crease (p = 0.0177), suggesting a blunted response in PNFLXports 13, 1965–1976, December 1, 2015 ª2015 The Authors 1971
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Figure 6. Altered Balance between DR and MR 5-HTergic Neuronal Activity in PNFLX Mice
(A–C) Fos and 5-HT immunostaining on hM3Dq+ and hM4Di+ mice and controls in DR (A) and MR (B) demonstrates an increase of in the percentage of Fos+/
5-HT+ neurons in hM3Dq+ mice when compared to control animals. Moreover, PNFLX control animals display an increase in the percentage of Fos+/5-HT+
neurons in the MR (B), but not the DR (A), when compared to PNSAL control animals. n = 3–9 per genotype, PNT, and region. Scale bars in (C), 20 mm on the left
panel and 100 mm on the right panel.
(D–G) The anatomical location of in vivo electrophysiological recordings of putative 5-HTergic raphe´ neurons was validated at the end of each recording session
through responsiveness to 5-HT1A-receptor-mediated inhibition of neuronal firing, achieved by 8-OH-DPAT administration (i.p., 1 mg/kg) (D and F). Insets show
examples of single extracellularly recorded spikes from PNSAL (plain lines) and PNFLX (dashed lines) animals. The firing frequency of putative 5-HTergic neurons
of PNFLX mice were reduced in the DR (E) but increased in the MR (G) when compared to PNSAL animals. n = 8–9 animals.
Data are presented as mean ± SEM. **p < 0.01; ***p < 0.005.RC::PDq;Pet1-cre mice: for GXTx, F(1, 36) = 12.342, p =
0.0012. Conversely, 5-HTergic neuronal activity in RC::PDi;-
Pet1-cre mice showed a 34% decrease in PNFLX mutants
(p = 0.0339) but only a 14% decrease in PNSAL mutants (p =
0.2350), with a trend for GXPNT interaction, F(1, 31) = 2.955,
p = 0.0956. These results are paralleling the behavioral re-
sponses in anxiety tests, where PNSAL animals were more
sensitive to increasing 5-HTergic neuronal activity, while PNFLX
animals were more sensitive to decreasing 5-HTergic neuronal
activity. Lastly, Fos analysis also indicates that MR 5-HTergic
neurons of PNFLX mice are more active at baseline than those
of PNSAL mice (controls in Figure 6B; Fisher’s PLSD, p =
0.0049). To further study this effect of PNFLX at baseline, we
recorded putative 5-HTergic neurons in vivo. Specifically, we
performed extracellular recordings within the DR and MR of
PNFLX and PNSAL animals. Neurons were classified as puta-
tively 5-HTergic based on their spike length and shape, as
well as by the efficient shutdown of neuronal activity upon in-
jection of the 5-HT1A receptor agonist, 8-OH-DPAT (1 mg/kg,
i.p.) (Figures 6D and 6F). As previously reported for mouse
models of increased depression-like behavior, we observed
decreased activity of putative 5-HTergic neurons in the DR of
PNFLX animals when compared to PNSAL controls (Figures1972 Cell Reports 13, 1965–1976, December 1, 2015 ª2015 The Aut6E and S5), F(1, 15) = 11.750, p = 0.0037. Conversely, and in
line with our Fos data, we observed increased activity of puta-
tive 5-HTergic neurons in the MR of PNFLX animals when
compared to PNSAL controls (Figures 6G and S5), F(1, 45) =
9.835, p = 0.003. These results demonstrate an altered balance
of raphe´ nuclei activity in PNFLX animals and support a role of
MR hyperfunction in the anxiety phenotype of PNFLX mice.
Furthermore, since activation of 5-HT neurons in naive and
PNSAL animals reduced floating behavior while inhibition of
5-HT neurons in PNFLX animals reduced floating behavior,
these results suggest that relatively increased MR 5-HTergic
activity over DR 5-HTergic activity is causing the depression-
like phenotype in PNFLX mice. Such a relational model for
depression-like behavior in the FST implies opposing effects
of DR versus MR 5-HTergic activity on floating behavior.
Antagonistic Effect of Rhombomere-1- or Rhombomere-
2-Derived 5-HT Neuronal Inhibition on Swimming
Behavior
To test whether DR and MR 5-HTergic activity exert opposing
effects on behavior in the FST, we took advantage of the dou-
ble conditional allele RC::FPDi, which allows for hM4Di ex-
pression only after both Cre-dependent and Flpe-dependenthors
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Figure 7. Opposing Consequences of r1 and r2 5-HTergic Neuronal Inhibition on FST Behavior
(A–E) In the FST, we assessed floating duration for r1-hM4Di+ mice (green lines) and their controls (black and gray lines) throughout the 6 min of FST upon Veh (A)
and CNO (B) injections and for the last 3min of the test (C) upon Veh (D) and CNO (E) injections. r1-hM4Di+ mice show increased floating behavior as compared to
controls when exposed to CNO (B and C), but not when exposed to Veh (A and C). r1-hM4Di+ mice, but not controls, show increased floating behavior after CNO
exposure when compared to Veh exposure (D and E). n = 11 per genotype.
(F–J) In the FST, we assessed floating duration for r2-hM4Di+ mice (green lines) and their controls (black and gray lines) throughout the 6 min of FST upon Veh (F)
and CNO (G) injections and for the last 3min of the test (H) upon Veh (I) and CNO (J) injections. r2-hM4Di+ mice show decreased floating behavior as compared to
controls when exposed to CNO (G and H), but not when exposed to Veh (F and H). r2-hM4Di+ mice, but not controls, show decreased floating behavior after CNO
exposure, when compared to Veh exposure (I and J). n = 18–25 per genotype.
Data are presented as mean ± SEM. *p < 0.05; **p < 0.01.recombination events have occurred in a given cell (Brust et al.,
2014; Ray et al., 2011). Using Pet1::Flpe and En1-cre, we
targeted hM4Di expression to rhombomere 1 (r1)-derived
5-HTergic neurons in En1-cre,Pet1::Flpe,RC::FPDi mice; using
Pet1::Flpe and Hoxa2-cre, we targeted hM4Di expression
rhombomere 2 (r2)-derived 5-HTergic neurons in Hoxa2-cre,
Pet1::Flpe,RC::FPDi mice (Brust et al., 2014). 5-HTergic neu-
rons generated in r1 contribute to DR and a portion of MR,
while a large fraction of MR 5-HTergic neurons are generated
in r2 and a further small fraction are generated in rhombomere
3 (r3) (Bang et al., 2012; Jensen et al., 2008). r1- and r2-hM4Di-
expressing triple transgenic animals and their respective sibling
controls (which did not carry the respective cre allele) were
tested in the OF, EPM, NSF, and FST. Of note, the En1-cre
line is a knockin (Kimmel et al., 2000), but we did not detect
an effect of genotype in any test performed (Figure 7; Figures
S6 and S7). We also did not detect a GXTx interaction on anx-
iety behaviors (Figures S6 and S7). However, as predicted by
our model, we observed opposing effects of r1 versus r2
5-HTergic neuron inhibition on floating behavior in the FST
paradigm. Specifically, inhibition of r1-derived 5-HT neurons
(En1-cre; Pet1::Flpe; RC::FPDi) increased floating behavior
(Figures 7A–7D); GXTx for minutes 4–6: F(1, 22) = 6.931, p =
0.0152. Conversely, CNO-driven inhibition of r2-derived 5-HT
neurons (Hoxa2-cre; Pet1::Flpe; RC::FPDI) resulted in
decreased floating (Figures 7E–7H); GXTx for minutes 4–6:
F(1, 43) = 9.789, p = 0.0031.Cell ReDISCUSSION
We find that pharmacogenetic activation of 5-HTergic neurons
elicits anxiogenic and antidepressant-like behavioral conse-
quences in naive animals. Emotional behavior, however,
appeared unchanged upon pharmacogenetic inhibition of
5-HTergic neuronal activity in naive mice. When tested in
PNFLX mice, anxiogenic and antidepressant-like behavioral
efficacy of 5-HTergic neuron activation was blunted while
5-HTergic neuron inhibition had anxiolytic and antidepres-
sant-like behavioral consequences. As a potential under-
lying neural mechanism, we identified reduced activity in DR
5-HTergic neurons but increased activity in MR 5-HTergic neu-
rons of PNFLX mice. Behavioral and physiological data
converge to suggest that MR hyperactivity drives the anxiety
phenotype, while a low DR/MR 5-HTergic activity ratio in-
creases depression-like behavior. In support of this model,
we identify opposing consequences of DR and MR 5-HTergic
neuron inhibition in naive mice, promoting and decreasing
FST immobility, respectively.
Pharmacogenetic Increase of 5-HT Neuronal Activity
Has Anxiogenic and Antidepressant-like Behavioral
Consequences
Increasing activity of 5-HTergic raphe´ neurons in both naive and
PNSAL animals decreased exploration, increased anxiety, and
decreased FST immobility. The co-occurrence of anxiogenicports 13, 1965–1976, December 1, 2015 ª2015 The Authors 1973
and antidepressant-like behavioral responses is congruent with
the effect of acute selective serotonin reuptake inhibitor (SSRI)
administration in rodents (Kurt et al., 2000) and humans (Sinclair
et al., 2009).Moreover, FST results alignwith the antidepressant-
like effect of increasing DR neuronal activity optogenetically
(Warden et al., 2012), while increased anxiety mirrors the conse-
quences of local optogenetic stimulation of MR 5-HT neurons
(Ohmura et al., 2014). Elucidating means to specifically and
separately target these behavioral consequences will be impor-
tant to guide drug development and improve therapeutic efficacy
and safety.
Decreasing activity of 5-HTergic raphe´ neurons in RC::PDi;
Pet1-cre mice did not produce behavioral effects. This finding
is surprising, considering the decreased DR 5-HTergic activity
in mouse models of depressive-like behavior (Bambico et al.,
2009; Lira et al., 2003; Veerakumar et al., 2014) and suggestive
evidence for decreased 5-HT signaling in depressed patients
(Blier et al., 1990; Gos et al., 2008). Furthermore, genetic models
with a lifelong decrease in 5-HT levels display increased depres-
sion-like behaviors and decreased anxiety (Kim et al., 2009;
Kiyasova et al., 2011; Mosienko et al., 2012; Narboux-Ne^me
et al., 2011). The chronic versus acute nature of manipulations
may contribute to differences in behavioral consequences. How-
ever, 5,7-DHT-induced 5-HT lesions also have no effect on anx-
iety and depression-like behavior, respectively (Borsini, 1995;
Lieben et al., 2006), indicating that development-specific factors
play a dominant role in behavioral consequences ofmany consti-
tutive genetic manipulations (Ansorge et al., 2004; Donaldson
et al., 2014; Gross et al., 2002; Suri et al., 2015). Importantly,
our pharmacogenetic inhibition protocol did alter behavior in
PNFLX mice, as well as in naive mice with r1- and r2-directed in-
hibition, demonstrating that the behavioral consequences of
decreasing 5-HTergic neuronal activity in adulthood vary drasti-
cally depending on the nature, specificity, and localization of the
manipulation.
PNFLX Animals Display a Blunted Response to
5-HTergic Neuronal Activation and Show Behavioral
Normalization after 5-HTergic Neuronal Inhibition
We find increased MR activity and decreased DR activity in
PNFLX mice. Furthermore, increasing 5-HT neuronal activity
produced blunted behavioral and physiological consequences,
while decreasing 5-HT neuronal activity restores normal anxiety
and depression-like phenotypes in PNFLX animals. Together
with the antidepressant effect of increased raphe´ activity in naive
and PNSAL animals, these results provide strong functional ev-
idence that an altered balance of raphe´ nuclei activity plays a
role in the etiology of mood disorders.
Our findings are consistent with anxiogenic consequences of
increasedMR activity (Ohmura et al., 2014) and anxiolytic effects
of MR lesions (Andrade et al., 1999; Pezzato et al., 2014). Of
note, one pharmacologic study suggests an anti-depressant ef-
fect of MR inhibition (Almeida et al., 2013). Furthermore,
increasing DR activity has an anti-depressant effect (Veeraku-
mar et al., 2014;Warden et al., 2012); however, the consequence
of decreasing DR activity and the contribution of DR 5-HTergic
neuronal activity to anxiety behavior still remains controversial
(Spoida et al., 2014; Warden et al., 2012).1974 Cell Reports 13, 1965–1976, December 1, 2015 ª2015 The AutSeveral converging mechanisms may play a role in differen-
tially impacting set points of MR and DR 5-HTergic neuronal ac-
tivity. First, between P2 and P21, DR—but not MR—5-HTergic
neurons undergo a molecular, morphological, and physiological
transition that appears crucial for its proper maturation, including
the establishment of 5-HT1a-dependent auto-inhibition (Donald-
son et al., 2014; Gross et al., 2002; Rood et al., 2014). Hence, a
post-natal increase in extracellular 5-HT levels might preferen-
tially affect the maturation of DR 5-HTergic neurons. Second,
developmental SSRI exposure may differentially alter the estab-
lishment of specific inputs onto DR andMR 5-HT neurons (Doro-
cic et al., 2014; Lechin et al., 2006), including those from local
GABAergic interneurons (Challis et al., 2013; Rood et al.,
2014). Finally, MR and DR send reciprocal projections to each
other (Bang et al., 2012; Muzerelle et al., 2014; Vertes et al.,
1999), and developmental interference with the establishment
of interconnectivity can lead to permanently altered relative
5-HTergic activity. Together, these mechanisms might converge
on permanently altering the balance between DR and MR
5-HTergic activity and provide a pathway for environmental
and genetic factors to guide, influence, or perturb 5-HTergic sys-
tem development.
r1- and r2-Derived 5-HTergic Neurons Display Opposing
Roles on Swimming Behavior
Weobserved that inhibition of r1-derived or r2-derived 5-HTergic
neurons has opposing effects on floating behavior in the FST,
while not affecting anxiety behavior. r1-derived 5-HT neurons
include DR neurons and the rostral part of the MR, while r2-
derived 5-HT neurons include the caudal part of the MR (Alonso
et al., 2013; Bang et al., 2012). The functional distinction of r1-
and r2-derived 5-HT neurons highlights the critical importance
of developmental origin for 5-HT neuron diversity, as previously
reported for 5-HT-dependent respiratory control (Brust et al.,
2014).
Increased floating behavior in the FST upon decreasing r1
5-HTergic activity is in line with decreased floating behavior after
increasing DR 5-HT activity (Veerakumar et al., 2014; Warden
et al., 2012) and supports a causal relationship of lowDR 5-HTer-
gic neuronal activity with depression-like behavior (Bambico
et al., 2009; Gos et al., 2008; Jacobsen et al., 2012; Lira et al.,
2003). In addition, decreased floating behavior upon decreasing
r2 5-HTergic activity also confirms a direct causal relationship
that was previously only suggested (Almeida et al., 2013). This
r1 versus r2 antagonism provides an explanation for the lack of
behavioral response in the FST upon global 5-HT neuronal inhi-
bition in wild-type (WT) mice. Interestingly though, if the normal
balance of 5-HTergic activity is altered, global inhibition of
5-HTergic neuronal activity can restore balance and normalize
behavior, as we found in PNFLX mice.
Several anatomical, physiological, and behavioral experi-
ments have previously indicated potential antagonistic effects
of DR and MR in psychopathologies (Lechin et al., 2006), yet
most preclinical studies focus on DR neurons and tend to gener-
alize to all 5-HTergic neurons. Going forward, it will be critical to
incorporate amuchmore differentiated view and investigate how
this opposing design and an imbalance of such can impact the
regulation of mood and behavior and mechanistically underliehors
the etiology of psychiatric disorders, such as major depression
and bipolar disorders.
EXPERIMENTAL PROCEDURES
Subjects
Mice (129SvEv/Tac) were bred at Columbia Psychiatry, New York State Psy-
chiatric Institute. Mice used for experiments were born to litters containing
4–8 pups. Mice were separated by sex and weaned into groups of five mice
per cage at P22. Animals were maintained on a 12-hr/12-hr light/dark cycle
(lights on at 8:00 a.m.) and provided with food and water ad libitum. Animal
testing was conducted in accordance with the NIH Guide for the Care and
Use of Laboratory Animals and the institutional animal committee guidelines
of the New York State Psychiatric Institute. For more information about behav-
ioral tests and drug treatments, see the Supplemental Experimental
Procedures.
Generation of the RC::PDq Line
The targeting construct for RC::PDq has a cassette including: the cytomega-
lovirus-chicken b-actin (CBA) promoter followed by a Pgk-Neomycin resis-
tance gene surrounded by two loxP sites, an HA (three copies)-tagged
DREADD receptor, an internal ribosome entry site (ires), and EGFP; this
cassette was targeted to the transcriptional start site of the mouse
Gt(ROSA)26 Sor locus (see also Figure S1).
Statistics
Data were analyzed with Student’s t test, one-way ANOVA, or two-way
ANOVA, with repeated-measures when appropriate (Statview). Post hoc ana-
lyses were conducted using Fisher’s PLSD. Datasets containing male and
female mice were analyzed for main effect and/or interaction of sex with the
dependent variables under study. Because none were found, male and female
data were combined. The criterion for significance was p < 0.05. All data are
presented as mean ± SEM. Numbers of animals are mentioned in the figure
legends.
The Supplemental Experimental Procedures contains a detailed description
of the generation of the RC::PDq mouse line, drug administration, behavioral
assays, electrophysiological recordings, microdialysis surgery, 5-HT level
analysis, and immunohistochemistry.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and seven figures and can be found with this article online at http://dx.doi.
org/10.1016/j.celrep.2015.10.061.
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